Literature DB >> 18378534

Familial risks for cancer as the basis for evidence-based clinical referral and counseling.

Kari Hemminki1, Jan Sundquist, Justo Lorenzo Bermejo.   

Abstract

OBJECTIVE: Reliable, clinically useful data on familial risks have not been available for all types of cancer, and familial aggregations of cancers, which are not known to belong to an inherited cancer syndrome, are often overlooked by medical referral systems. We provide uniform data on familial risks in all common cancers.
METHODS: The nationwide Swedish Family-Cancer Database includes 11.5 million individuals, born in 1932 and later, along with their parents. Standardized incidence ratios (SIRs) were calculated for age-specific familial risks in offspring.
RESULTS: The familial risks for offspring cancer were increased at 24 of 25 sites when a parent was diagnosed with concordant cancer, at 20 of 24 sites when a sibling was affected, and at 14 of 16 sites when a parent and at least one other sibling were affected. Among the offspring of affected parents, testicular cancer showed the highest risk, 4.52, followed by Hodgkin's disease (3.95) and esophageal cancer (3.36). At many sites, the risks between siblings were higher than those between offspring and affected parents, probably in part because of childhood environmental effects.
CONCLUSIONS: The data show convincingly that familial clustering is a common feature for all cancer sites. The results will be helpful in implementing evidence-based guidelines for clinical genetic counseling and in facilitating the recognition of familial risk at all levels of the general medical referral system.

Entities:  

Mesh:

Year:  2008        PMID: 18378534     DOI: 10.1634/theoncologist.2007-0242

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  14 in total

1.  The prospect of genome-guided preventive medicine: a need and opportunity for genetic counselors.

Authors:  Julianne M O'Daniel
Journal:  J Genet Couns       Date:  2010-05-04       Impact factor: 2.537

2.  Breast and prostate cancer: familial associations.

Authors:  Kari Hemminki; Asta Försti; Bowang Chen
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

Review 3.  [Pathogenesis of multiple myeloma].

Authors:  L Rasche; N Weinhold
Journal:  Internist (Berl)       Date:  2019-01       Impact factor: 0.743

4.  Heredity, diet and lifestyle as determining risk factors for the esophageal cancer on Nanao Island in Southern China.

Authors:  Min Liu; Min Su; Dong-Ping Tian; Guo-Hong Zhang; He-Lin Yang; Yu-Xia Gao
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

5.  Familial risk and familial survival in prostate cancer.

Authors:  Kari Hemminki
Journal:  World J Urol       Date:  2011-11-25       Impact factor: 4.226

6.  Provision of cardiovascular genetic counseling services: current practice and future directions.

Authors:  Allyson E Somers; Stephanie M Ware; Kathleen Collins; John L Jefferies; Hua He; Erin M Miller
Journal:  J Genet Couns       Date:  2014-05-01       Impact factor: 2.537

Review 7.  Hereditary Factors in Esophageal Adenocarcinoma.

Authors:  Anna M J van Nistelrooij; Winand N M Dinjens; Anja Wagner; Manon C W Spaander; J Jan B van Lanschot; Bas P L Wijnhoven
Journal:  Gastrointest Tumors       Date:  2014-05-09

8.  An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma.

Authors:  Megan E Downing; Gillian S Dite; Mandy L Ballinger
Journal:  Clin Sarcoma Res       Date:  2012-01-09

9.  Age of onset in familial breast cancer as background data for medical surveillance.

Authors:  A Brandt; J Lorenzo Bermejo; J Sundquist; K Hemminki
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

10.  Younger age-at-diagnosis for familial malignant testicular germ cell tumor.

Authors:  Phuong L Mai; Bingshu E Chen; Kathy Tucker; Michael Friedlander; Kelly-Anne Phillips; David Hogg; Michael A S Jewett; Istvan Bodrogi; Lajos Geczi; Edith Olah; Ketil Heimdal; Sophie D Fosså; Katherine L Nathanson; Larissa Korde; Douglas F Easton; Darshna Dudakia; Robert Huddart; Michael R Stratton; D Timothy Bishop; Elizabeth A Rapley; Mark H Greene
Journal:  Fam Cancer       Date:  2009-07-17       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.